A propensity score-matched retrospective study on sacubitril/valsartan use and 6-month readmission rates in patients with acute heart failure
In-hospital use of sacubitril/valsartan does not significantly reduce the risk of 6-month readmission in patients with newly diagnosed acute heart failure.
Authors
- Guofei Ren
- L. Zhang (ORCID: https://orcid.org/0000-0002-3617-7647)
- Qinglian Chen
Institutions
- Affiliated Hospital of Hangzhou Normal University (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-09-29
- DOI
- https://doi.org/10.7717/peerj.20055
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00